[Immunology of type-1 diabetes. The initial stages in a causal therapy].
D000293:Adolescent; D000328:Adult; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D000936:Antigen-Antibody Complex / Q000032:analysis; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology / Q000628:therapy; D002464:Cell Migration Inhibition; D002648:Child; D003524:Cyclosporins / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007167:Immunotherapy / Q000379:methods; D007515:Islets of Langerhans / Q000276:immunology; D007962:Leukocytes / Q000276:immunology; D008875:Middle Aged; D016035:Pancreas Transplantation; D051381:Rats; D011913:Rats, Inbred BB
D000906:Antibodies; D000936:Antigen-Antibody Complex; D003524:Cyclosporins
Immunologie des Typ-I-Diabetes. Erste Ansätze zu einer kausalen Therapie.